PROCEPT BioRobotics Corporation (PRCT) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30..
Borrowing debt
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 51.72M USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 479.35M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | $51.72M | (m) | (m) | $479.35M | (m) |
| 2026-03-31 | (m) | (m) | (m) | $51.66M | (m) | (m) | $487.06M | (m) |
| 2025-12-31 | (m) | (m) | (m) | $51.62M | (m) | (m) | $508.08M | (m) |
| 2025-09-30 | (m) | (m) | (m) | $51.57M | (m) | (m) | $511.54M | (m) |
| 2025-06-30 | (m) | (m) | (m) | $51.52M | (m) | (m) | $513.05M | (m) |
| 2025-03-31 | (m) | (m) | (m) | $51.50M | (m) | (m) | $519.38M | (m) |
| 2024-12-31 | (m) | (m) | (m) | $51.47M | (m) | (m) | $534.02M | (m) |
| 2024-09-30 | (m) | (m) | $0.00 | $51.44M | (m) | (m) | $374.14M | (m) |
| 2024-06-30 | (m) | (m) | $0.00 | $51.40M | (m) | (m) | $374.35M | (m) |
| 2024-03-31 | (m) | (m) | $0.00 | $51.37M | (m) | (m) | $382.90M | (m) |
| 2023-12-31 | (m) | (m) | (m) | $51.34M | (m) | (m) | $404.72M | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | $51.31M | (m) | (m) | $421.13M | (m) |
| 2023-06-30 | (m) | (m) | $0.00 | $51.27M | (m) | (m) | $272.45M | (m) |
| 2023-03-31 | (m) | (m) | $0.00 | $51.24M | (m) | (m) | $284.46M | (m) |
| 2022-12-31 | (m) | (m) | (m) | $51.21M | (m) | (m) | $309.33M | (m) |
| 2022-09-30 | (m) | (m) | $0.00 | $50.69M | (m) | (m) | $324.04M | (m) |
| 2022-06-30 | (m) | (m) | $0.00 | $50.51M | (m) | (m) | $310.93M | (m) |
| 2022-03-31 | (m) | (m) | $0.00 | $50.25M | (m) | (m) | $320.91M | (m) |
| 2021-12-31 | (m) | (m) | $0.00 | $50.00M | (m) | (m) | $337.02M | (m) |
| 2021-09-30 | (m) | (m) | $0.00 | $49.76M | (m) | (m) | $351.46M | (m) |
| 2020-12-31 | (m) | (m) | $4.55M | $44.41M | (m) | (m) | $125.97M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |